Topics
Glioblastoma | Treatment | Clinical trials | Lomustine
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Lomustine
Preusser
M, Kazda T, Le Rhun E, Sahm F, Smits M, Gempt J, Koekkoek JA,
Monti AF, Csanadi M, Pitter JG, Bulbek H, Fournier B, Quoilin C,
Gorlia T, Weller M, Minniti G; European Organisation for Research,
Treatment of Cancer (EORTC) Brain Tumor Group.
Lomustine
with or without reirradiation for first progression of
glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a
randomized phase III study.
Trials.
2024 Jun 7;25(1):366. doi:
10.1186/s13063-024-08213-7. PMID:
38849943. Interventional study protocol. ˍ